[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100597416":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":26,"locations":35,"responsibleParty":52,"collaborators":54,"id":59,"slug":60,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":65,"eligibilityCriteria":66,"healthyVolunteers":61,"sex":67,"minAge":68,"maxAge":20,"enrollmentInfo":69,"targetDuration":20,"studyType":72,"phases":73,"briefSummary":75,"conditions":76,"keywords":81,"overallStatus":38,"whyStopped":20,"lastUpdateSubmitDate":97,"lastUpdatePostDateStruct":98,"startDateStruct":101,"completionDateStruct":103,"leadSponsor":105,"locationsCount":106},{"fullName":5,"class":6},"Institut d'Investigació Biomèdica de Bellvitge","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Cancer patients with obesity with active curative treatment","EXPERIMENTAL","Fifty adult cancer patients with obesity (BMI ≥30 kg\u002Fm²) newly diagnosed with stage II-IV solid tumors undergoing curative-intent treatment. Participants will receive a multimodal weight management program combining dietary intervention, physicial activity and behavioral support.",[13],"Behavioral: Multimodal weight management program",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"BEHAVIORAL","Multimodal weight management program","This intervention consists of three components:\n\n* Nutritional Counseling:\n\n  * A personalized hypocaloric and high-protein diet is prescribed, based on individual energy requirements with a 20% caloric reduction.\n  * The protein intake target is 1.5 g\u002Fkg\u002Fday to promote fat loss while maintaining muscle mass.\n* Exercise Program\n\n  * Home-based, supervised aerobic and resistance training sessions conducted 3 times per week.\n  * Each 60-minute session includes: 5 minutes flexibility, 25 minutes aerobic training, 25 minutes resistance training, and 5 minutes balance exercises.\n* Behavioral Support\n\n  * Patients receive training in problem-solving strategies, motivation, and emotional self-regulation to improve adherence to both dietary and exercise goals.\n  * Health professionals delivering the intervention are trained in behavior change techniques by a clinical psychologist.",[9],null,[22],{"name":23,"affiliation":24,"role":25},"Lorena Arribas, PhD, MsC, RD","Catalan Institute of Oncology (ICO-Hospitalet). Bellvitge Biomedical Research Institute (IDIBELL)","PRINCIPAL_INVESTIGATOR",[27,32],{"name":28,"role":29,"phone":30,"phoneExt":20,"email":31},"Lorena Arribas","CONTACT","+34932607751","larribas@iconcologia.net",{"name":33,"role":29,"phone":30,"phoneExt":20,"email":34},"Marta Puig","mpuig@iconcologia.net",[36],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Institut Català d'Oncologia. Catalan Institute of Oncology","RECRUITING","L'Hospitalet de Llobregat","Barcelona","08908","Spain","ES",{"type":45,"coordinates":46},"Point",[47,48],2.10028,41.35967,{"lat":48,"lon":47},[51],{"name":28,"role":29,"phone":30,"phoneExt":20,"email":31},{"type":25,"investigatorFullName":28,"investigatorTitle":53,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"Principal Investigator",[55,57],{"name":56,"class":6},"World Cancer Research Fund International",{"name":58,"class":6},"Institut Català d'Oncologia","100597416","weight-management-in-obese-cancer-patients-during-curative-active-treatment-100597416",false,"NCT07058207","Weight Management in Obese Cancer Patients During Curative Active Treatment","Weight Management in Obese Cancer Patients During Curative Active Treatment (CANOBESE Study): A Feasibility Study","CANOBESE","Inclusion Criteria:\n\n* Adult (age 18+) with pathologically confirmed malignant solid tumors, stage II-IV, elected for oncological treatment (chemo, radio, or both) with curative intend.\n* Expected oncological treatment time ≥ 3 months.\n* BMI ≥ 30 kg\u002Fm²\n* Resident in the Barcelona area up to the completion of cancer treatment.\n* ECOG Perfomance Status (PS) 0-1\n* Availability of internet access.\n\nExclusion Criteria:\n\n* Patients with melanoma and brain tumours.\n* Surgery as the only treatment.\n* Tumour localizations with high risk of malnutrition (such as head and neck, upper gastrointestinal tract, or pancreatic cancer):\n* Pregnancy or breastfeeding\n* Another active malignancy\n* Current health or medical condition that affects weight status, e.g., untreated hyper- or hypothyroidism,etc\n* Pre-existing medical condition that precludes adherence to unsupervised exercise, e.g., severe orthopedic conditions, scheduled for a hip or knee replacement, bone metastases, paralysis, dementia, untreated stage 3 hypertension, or unstable angina, heart attack, congestive heart failure or conditions that dictated hospitalization or oxygen within 6-months.\n* Unable to read or understand Spanish or Catalan\n* Enrolled in a weight loss program\n* Active suicidal ideation, anorexia, bulimia, binge eating disorder, current substance abuse or dependence (besides nicotine dependence)\n* Use of pacemaker or another electrical implanted device\n* History of bariatric (or LapBand) surgery, or considering or currently on a wait-list for bariatric or LapBand surgery\n* Patients with any concurrent medical or psychological condition that, in the investigator's opinion, would jeopardize the safety of the patient or compliance with the protocol.","ALL","18 Years",{"count":70,"type":71},50,"ESTIMATED","INTERVENTIONAL",[74],"NA","This is a feasibility study intervention to fifty cancer patients with obesity and with newly diagnosed stage II-IV solid tumors undergoing curative treatment recruited at the Catalan Institute of Oncology (ICO) in L'Hospitalet, Spain.\n\nThe investigators hypothesize that weight management during cancer treatment could enhance health outcomes for this population. The feasibility of a multimodal weight loss management program will be assesses, including a personalized hypocaloric and high-protein diet combined with a supervised exercise home-program and behavioural support.",[77,78,79,80],"Obesity","Solid Neoplasm","Stage II-IV","Curative Treatment",[77,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96],"Neoplasms","Antineoplasic agents","Chemotherapy","Radiotherapy","Weight Loss","Physical Activity","Feasibility Studies","Patient Compliance","Patient Motivation","Patient Adherence","Patient Dropouts","Treatment-related adverse effects","Biomarkers","nutritional intervention","curative-intent treatment","2025-07-24",{"date":99,"type":100},"2025-07-28","ACTUAL",{"date":102,"type":100},"2025-07-22",{"date":104,"type":71},"2027-03",{"name":5,"class":6},1]